ArticleEcancermedicalscience2026
Gastric cancer, what's new from International Gastric Cancer Congress (IGCC) in Amsterdam: a scientific report from Salerno 2025 conference.
Article in Ecancermedicalscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper presents a critical synthesis of the national conference "Gastric Cancer at Ruggi d'Aragona", held in Salerno, Italy, in June 2025. The event gathered over 200 specialists to discuss recent advances in the multidisciplinary management of gastric cancer. Key topics included precision surgery, integration of imaging and molecular profiling, innovations in minimally invasive and robotic techniques, and emerging strategies such as conversion therapy and neoadjuvant immunotherapy. Insights from the 16th International Gastric Cancer Congress highlighted global trends, including the rise of targeted and immunologic approaches and the expansion of collaborative networks. The analysis identifies gaps between technological potential and clinical implementation and outlines future priorities for research and healthcare organization. This report aims to inform clinical practice and foster interdisciplinary reflection on the evolving management of gastric cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.